Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.
2.

Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea.

Morelli MS, Rouster SD, Giannella RA, Sherman KE.

Clin Gastroenterol Hepatol. 2004 Aug;2(8):669-74.

PMID:
15290659
4.

Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.

Humphries RM, Uslan DZ, Rubin Z.

J Clin Microbiol. 2013 Mar;51(3):869-73. doi: 10.1128/JCM.02970-12. Epub 2012 Dec 26.

5.
6.

Evaluation of repeat Clostridium difficile enzyme immunoassay testing.

Cardona DM, Rand KH.

J Clin Microbiol. 2008 Nov;46(11):3686-9. doi: 10.1128/JCM.00931-08. Epub 2008 Sep 24.

7.

[Experience with laboratory diagnosis of Clostridium difficile].

Bareková L, Zálabská E, Hanovcová I.

Klin Mikrobiol Infekc Lek. 2013 Sep;19(3):91-5. Czech.

PMID:
24579451
8.

Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.

Deshpande A, Pasupuleti V, Patel P, Ajani G, Hall G, Hu B, Jain A, Rolston DD.

Clin Gastroenterol Hepatol. 2011 Aug;9(8):665-669.e1. doi: 10.1016/j.cgh.2011.04.030. Epub 2011 May 13.

PMID:
21635969
9.

Lack of value of repeat stool testing for Clostridium difficile toxin.

Mohan SS, McDermott BP, Parchuri S, Cunha BA.

Am J Med. 2006 Apr;119(4):356.e7-8.

PMID:
16564786
10.

Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection.

Baker I, Leeming JP, Reynolds R, Ibrahim I, Darley E.

J Hosp Infect. 2013 Aug;84(4):311-5. doi: 10.1016/j.jhin.2013.05.006. Epub 2013 Jul 5.

PMID:
23831282
11.

Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.

Nemat H, Khan R, Ashraf MS, Matta M, Ahmed S, Edwards BT, Hussain R, Lesser M, Pekmezaris R, Dlugacz Y, Wolf-Klein G.

Am J Gastroenterol. 2009 Aug;104(8):2035-41. doi: 10.1038/ajg.2009.174. Epub 2009 Apr 14.

PMID:
19367273
12.

Comparison of testing approaches for Clostridium difficile infection at a large community hospital.

Grein JD, Ochner M, Hoang H, Jin A, Morgan MA, Murthy AR.

Clin Microbiol Infect. 2014 Jan;20(1):65-9. doi: 10.1111/1469-0691.12198. Epub 2013 Mar 23.

13.

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).

Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ.

Clin Microbiol Infect. 2009 Dec;15(12):1053-66. doi: 10.1111/j.1469-0691.2009.03098.x. Review.

14.

Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.

Mattner F, Winterfeld I, Mattner L.

Scand J Infect Dis. 2012 Aug;44(8):578-85. doi: 10.3109/00365548.2012.655772. Epub 2012 Mar 11.

PMID:
22404319
15.

Repeated enzyme immunoassays have limited utility in diagnosing Clostridium difficile.

Drees M, Snydman DR, O'Sullivan CE.

Eur J Clin Microbiol Infect Dis. 2008 May;27(5):397-9. doi: 10.1007/s10096-007-0452-8. Epub 2008 Jan 9.

PMID:
18189148
16.
18.

Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.

Goldenberg SD, Cliff PR, Smith S, Milner M, French GL.

J Hosp Infect. 2010 Jan;74(1):48-54. doi: 10.1016/j.jhin.2009.08.014. Epub 2009 Nov 8.

PMID:
19900734
19.
20.

Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.

Napierala M, Munson E, Skonieczny P, Rodriguez S, Riederer N, Land G, Luzinski M, Block D, Hryciuk JE.

Diagn Microbiol Infect Dis. 2013 Aug;76(4):534-8. doi: 10.1016/j.diagmicrobio.2013.04.020. Epub 2013 Jun 2.

PMID:
23731555

Supplemental Content

Support Center